IL2 and tuberculosis: Aagaard et al. demonstrated that the H56/CAF01 vaccine improved the multifunctional CD4+ T cell populations secreting IFN-γ+IL-2+ and IFN-γ+IL-2+TNF-α+ and evoked a level of protection against TB comparable to that evoked by BCG (42).